Does cannabis represent a turning point for the pharmaceutical industry?

Will THC and CBD products redefine how we approach and treat disease?

When will the scientific community find meaningful benefits that debunk the international classification of cannabis as a Schedule 1 narcotic?

The answers to these questions will significantly impact the cannabis industry. Anyone with business interests in marijuana, hemp and/or CBD need to understand the role of science and research in the future of cannabis as a global commodity.

MJBizDaily designs conferences to deliver thorough, straightforward education across all sectors of cannabusiness — ancillary or plant-touching, investing or cultivating, research or retail.

Our science and research track at MJBizConINT’L provides a valuable overview of the latest academic developments paired with actionable solutions for cannabis professionals. Learn how to foster commercial relationships with medical associations, hear the latest in cannabis clinical trials, and find out how universities and governments around the world are playing a major role in the advancement of cannabis research.

Medicinal Research Benefits Recreational Use

Separate approaches to medicinal and recreational markets have benefitted cannabis progress in several ways. MJBizConNEXT Keynote Speaker Kevin O’Leary emphasized the value of approaching cannabis legalization by first lifting federal restrictions on medical use as a precedent for introducing recreational consumption.

“If there was a federally legal, medicinal solution, [lawmakers] would see the taxes and the jobs – and it would make it a lot easier to pursue recreational mandates,” O’Leary said in an interview with MJBizDaily.

Understanding the Science Driving Global Cannabis Research

The Science & Research conference sessions at MJBizConINT’L are thoughtfully designed with a holistic perspective on these questions. The editors of MJBizDaily have selected expert speakers and compiled panels of accomplished professionals to deliver comprehensive analyses of the cannabis industry as it relates to business ventures worldwide.

You’ll see how different nations approach the industry with research, whether by justifying medical applications in the MMJ community or disproving safety concerns curtailing the adoption of recreational use, plus new and surprising developments.

Our Science & Research conference tracks are designed to inform your business decisions

• How to Use Science & Research to Boost Your Cannabis Business
  Specialists from Colombia and the United States translate technical analysis into practical applications so you can harness science to expand your impact on cannabis. Learn how to turn R&D into licensed intellectual property, develop strong commercial relationships with medical associations and potential distribution partners, and harness additional methods to use science and research for advancement. Learn More >>
• Latest Academic Research
  In this “one-stop shop” session, cannabis researchers from Israel, Australia and the United States explore academic efforts and advances around the world. You’ll get insights into fascinating aspects of cannabis clinical trials, barriers to cannabis research, and a glimpse at the wide-ranging impacts of academic efforts on the global cannabis market. Plus, you’ll hear updates on the quest to understand the role of terpenes in the entourage effect. Learn More >>
• The Future of Science & Research
  Experts from Canada, Israel and Peru will share what excites them most about the future of marijuana. Cannabis science is still a young field, leaving scores of questions about marijuana’s effects and applications for modern researchers to explore. Learn which diseases researchers hope to combat with THC and CBD, see new applications for cannabis (like cosmetics and veterinary medicines), and discern the seemingly infinite possibilities for commercial research. Learn More >>

If you’re ready to actively incorporate research into your business strategy, you’ll want to hear from Stephen Konigsberg, managing director and general counsel of Tikun Olam. His session, Business Insights: Creating a “Dual Track” Cannabis Business: Pharmaceutical & Medical/Adult-Use, explores how businesses can operate in both medical and adult-use cannabis.

Despite divisions between the two markets, marijuana is evolving into a commodity attracting major revenue — regardless of how it’s categorized for consumers.

View the full INT’L conference agenda to learn more about our seven distinct speaker tracks, each uniquely designed to inform international business considerations in the cannabis industry.

This blog post was originally published for MJBizTalks